Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-15 4:57 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Lytton, Laurence W. | 3,689,920 9.300% | 1,041,770 (+39.34%) | Filing History |
| 2022-02-15 2:25 pm Sale | 2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC | Lytton, Laurence W. | 1,071,970 4.100% | -308,296 (-22.34%) | Filing History |
| 2022-02-15 2:18 pm Sale | 2021-12-31 | 13G | VERTEX ENERGY INC VTNRQ | Lytton, Laurence W. | 3,649,067 5.700% | -444,494 (-10.86%) | Filing History |
| 2022-02-15 2:16 pm Purchase | 2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Lytton, Laurence W. | 43,474 6.800% | 3,107 (+7.70%) | Filing History |
| 2022-02-15 1:50 pm Sale | 2021-12-31 | 13G | Ra Medical Systems, Inc. RMED | Lytton, Laurence W. | 4,400 0.800% | -419 (-8.70%) | Filing History |
| 2022-02-15 1:49 pm Sale | 2021-12-31 | 13G | EMCORE Corporation EMKR | Lytton, Laurence W. | 65,279 1.800% | -106,552 (-62.01%) | Filing History |
| 2022-02-15 1:48 pm Purchase | 2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | Lytton, Laurence W. | 255,876 0.700% | 255,876 (New Position) | Filing History |
| 2022-02-15 1:09 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Lytton, Laurence W. | 85,416 2.500% | -81,604 (-48.86%) | Filing History |
| 2022-02-14 7:50 pm Sale | 2021-12-31 | 13G | Duos Technologies Group, Inc. DUOT | Lytton, Laurence W. | 214,700 5.900% | -1,000 (-0.46%) | Filing History |
| 2022-02-14 7:45 pm Purchase | 2021-12-31 | 13G | Giga-tronics Incorporated GIGA | Lytton, Laurence W. | 274,951 9.990% | 27,251 (+11.00%) | Filing History |
| 2022-02-14 7:44 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 13,926 6.600% | -1,887 (-11.94%) | Filing History |
| 2021-12-30 12:27 pm Purchase | 2021-12-20 | 13G | LiqTech International, Inc. LIQT | Lytton, Laurence W. | 276,247 10.400% | 35,974 (+14.97%) | Filing History |
| 2021-10-06 4:19 pm Purchase | 2021-09-26 | 13G | DiaMedica Therapeutics Inc. DMAC | Lytton, Laurence W. | 1,380,266 5.200% | 1,380,266 (New Position) | Filing History |
| 2021-03-05 7:26 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | Lytton, Laurence W. | 167,020 7.000% | 30,666 (+22.49%) | Filing History |
| 2021-03-05 4:55 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | Lytton, Laurence W. | 136,354 5.700% | 136,354 (New Position) | Filing History |
| 2021-02-16 12:24 pm Sale | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | Lytton, Laurence W. | 0 0.000% | -1,010,718 (Position Closed) | Filing History |
| 2021-02-16 11:46 am Purchase | 2020-12-31 | 13G | VERTEX ENERGY INC VTNRQ | Lytton, Laurence W. | 4,093,561 9.000% | 4,093,561 (New Position) | Filing History |
| 2021-02-16 11:43 am Purchase | 2020-12-31 | 13G | Ra Medical Systems, Inc. RMED | Lytton, Laurence W. | 4,819 7.700% | 4,819 (New Position) | Filing History |
| 2021-02-16 11:39 am Sale | 2020-12-31 | 13G | LiqTech International, Inc. LIQT | Lytton, Laurence W. | 240,273 8.700% | -31,963 (-11.74%) | Filing History |
| 2021-02-16 11:37 am Purchase | 2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Lytton, Laurence W. | 40,368 9.990% | 40,368 (New Position) | Filing History |